Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl

Compare
Equity
Direct
Sector - Healthcare
NAV: ₹ 28.59 as on 12-04-2024
Fund Performance
zero opening, trading, fund transfer fee
28 people have invested ₹ 65.8K in Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl in the last three months

About the Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl is an equity fund. This fund was started on 28 December, 2015. The fund is managed by Meeta Shetty. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl has ₹879 Cr worth of assets under management (AUM) as on Feb 2024 and is less than category average.
  2. The fund has an expense ratio 0.8.

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl Overview

Expense ratio
Expense ratio
0.84%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹879 Cr
Inception Date
Inception Date
28 December, 2015
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹100
Exit Load
Exit Load
0.25%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
23.3%

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl Distribution as on (29-Feb-24)

  • Equity 95.9%

  • Debt & Cash 4.1%

Size breakup

Large cap
38.3%
Mid cap
37.6%
Small cap
20%
Sector Allocation

Feb'24

Jan'24

Dec'23

Health
98.1%
Basic Materials
1.9%

Top Holdings of Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl as on (31-Mar-24)

  • Equity

Equity Holdings31

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl: Monthly Changes Updates

All changes are between Dec'23 and Feb'24
Fund Performance
Feb'24
Jan'24
Dec'23
Fund Returns
4.57%
6.24%
3.77%
Nifty 500
1.58%
1.71%
7.25%
  • This fund’s returns stands at 4.57% whereas the fund’s underlying benchmark Nifty 500 returns stands at 1.58% as on Feb'24
  • This fund outperformed Nifty 500 by 2.99% in Feb'24
AUM Change
Parameters
Feb'24
Jan'24
Dec'23
AUM
₹ 872.2 Cr
₹ 842.8 Cr
₹ 759.6 Cr
  • AUM of the fund stands at 872.2 Cr as of Feb'24
  • AUM increased by 29.4 Cr between Feb'24 and Jan'24
Fund Portfolio Changes

Gainers & Losers in Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl portfolio Returns for the month of Feb

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl Fund Manager

Meeta Shetty
Meeta Shetty
Fund Manager of Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl, since 9 March 2021

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 13.72% since inception which is less than its category average return of 21.2%
Fund Allocations

Fund Allocations

This fund has an allocation of 95.86% in Equity, 0% in Debt and 4.14% in Cash related instruments
AUM size ₹879 Cr

AUM size ₹879 Cr

This fund has AUM of ₹879 Cr which is less than its category average of ₹ 1650 Cr
Expense Ratio 0.84%

Expense Ratio 0.84%

This fund has an expense ratio of 0.84% which is less than its category average expense ratio of 1.45%

Frequently Asked Questions

The current NAV of Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl is ₹28.59 as on 12-Apr-2024.
Existing (Absolute + CAGR) as on 12-Apr-2024.
Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl
Absolute Returns
CAGR Returns
1 Month Returns
1.46%
1.46%
6 Month Returns
28.02%
28.02%
1 Year Returns
59.62%
59.62%
3 Years Returns
71.11%
19.61%
5 Years Returns
200.67%
24.63%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.84% as on March 2024
₹879 Cr as on March 2024
Sun Pharmaceuticals Industries Ltd(14.56%), Lupin Ltd(9.39%), Aurobindo Pharma Ltd(8.87%), Cipla Ltd(7.07%), Zydus Lifesciences Ltd(5.4%) as on March 2024
The alpha ratio for the Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl
4.62
5
9.21
As on March 2024
The alpha for Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl
0.9
0.9
0.75
As on March 2024
The Beta for Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl
2.91
1.02
1.07
As on March 2024
The sharpe ratio for Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl
14.47
14.86
17.08
As on March 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.94 as on March 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.96 as on March 2024. It tells the consistency of the fund in generating superior risk-adjusted performance
Meeta Shetty is the fund manager of Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl
The Exit load of Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl is 0.25%